Guangxi LiuYao Group Co., Ltd (603368.SS)
CNY 18.49
(-0.59%)
CNY 18.49
(-0.59%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.39 Billion CNY | 8.4% |
| 2022 | 1.03 Billion CNY | 7.64% |
| 2021 | 964.78 Million CNY | 11.71% |
| 2020 | 863.61 Million CNY | 12.7% |
| 2019 | 766.32 Million CNY | 41.6% |
| 2018 | 541.18 Million CNY | 41.66% |
| 2017 | 382.04 Million CNY | 23.48% |
| 2016 | 309.38 Million CNY | 20.58% |
| 2015 | 256.58 Million CNY | 15.91% |
| 2014 | 221.36 Million CNY | 26.71% |
| 2013 | 174.7 Million CNY | 23.79% |
| 2012 | 141.12 Million CNY | 39.82% |
| 2011 | 100.93 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 263.77 Million CNY | 4.45% |
| 2024 Q3 | 272.53 Million CNY | 26.38% |
| 2024 Q1 | 252.53 Million CNY | -28.4% |
| 2023 Q3 | 272.22 Million CNY | 5.92% |
| 2023 Q1 | 243.8 Million CNY | -24.65% |
| 2023 Q2 | 257.02 Million CNY | 5.42% |
| 2023 Q4 | 352.71 Million CNY | 29.57% |
| 2023 FY | 1.12 Billion CNY | 8.4% |
| 2022 Q3 | 244.29 Million CNY | 2.74% |
| 2022 Q1 | 232.84 Million CNY | -14.86% |
| 2022 FY | 1.03 Billion CNY | 7.64% |
| 2022 Q4 | 323.58 Million CNY | 32.46% |
| 2022 Q2 | 237.77 Million CNY | 2.12% |
| 2021 Q3 | 265.09 Million CNY | 16.99% |
| 2021 Q1 | 199.61 Million CNY | -31.82% |
| 2021 FY | 964.78 Million CNY | 11.71% |
| 2021 Q2 | 226.6 Million CNY | 13.52% |
| 2021 Q4 | 273.47 Million CNY | 3.16% |
| 2020 Q3 | 219.99 Million CNY | 20.74% |
| 2020 Q4 | 292.77 Million CNY | 33.08% |
| 2020 FY | 863.61 Million CNY | 12.7% |
| 2020 Q1 | 168.63 Million CNY | -30.08% |
| 2020 Q2 | 182.21 Million CNY | 8.05% |
| 2019 Q3 | 203.97 Million CNY | 26.48% |
| 2019 Q2 | 161.27 Million CNY | 0.87% |
| 2019 Q1 | 159.88 Million CNY | -14.39% |
| 2019 FY | 766.32 Million CNY | 41.6% |
| 2019 Q4 | 241.19 Million CNY | 18.24% |
| 2018 Q4 | 186.75 Million CNY | 33.66% |
| 2018 Q3 | 139.72 Million CNY | 21.21% |
| 2018 FY | 541.18 Million CNY | 41.66% |
| 2018 Q2 | 115.26 Million CNY | 15.91% |
| 2018 Q1 | 99.44 Million CNY | -11.94% |
| 2017 Q2 | 86.31 Million CNY | 6.61% |
| 2017 Q4 | 112.92 Million CNY | 10.89% |
| 2017 FY | 382.04 Million CNY | 23.48% |
| 2017 Q1 | 80.96 Million CNY | -9.46% |
| 2017 Q3 | 101.83 Million CNY | 17.98% |
| 2016 Q3 | 73.79 Million CNY | 6.66% |
| 2016 FY | 309.38 Million CNY | 20.58% |
| 2016 Q4 | 89.43 Million CNY | 21.19% |
| 2016 Q2 | 69.19 Million CNY | -10.1% |
| 2016 Q1 | 76.96 Million CNY | 13.61% |
| 2015 Q3 | 66.84 Million CNY | 10.01% |
| 2015 FY | 256.58 Million CNY | 15.91% |
| 2015 Q1 | 61.23 Million CNY | -5.79% |
| 2015 Q2 | 60.76 Million CNY | -0.78% |
| 2015 Q4 | 67.74 Million CNY | 1.35% |
| 2014 Q3 | 55.99 Million CNY | 13.42% |
| 2014 Q4 | 65 Million CNY | 16.08% |
| 2014 FY | 221.36 Million CNY | 26.71% |
| 2014 Q2 | 49.37 Million CNY | -3.18% |
| 2014 Q1 | 50.99 Million CNY | 4.84% |
| 2013 Q3 | 46.76 Million CNY | 0.0% |
| 2013 FY | 174.7 Million CNY | 23.79% |
| 2013 Q4 | 48.64 Million CNY | 4.01% |
| 2012 FY | 141.12 Million CNY | 39.82% |
| 2011 FY | 100.93 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| China Meheco Group Co., Ltd. | 2.71 Billion CNY | 48.431% |
| Liaoning Cheng Da Co., Ltd. | 1.77 Billion CNY | 21.074% |
| Shanghai Pharmaceuticals Holding Co., Ltd | 23.26 Billion CNY | 93.99% |